|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Heron Therapeutics (NASDAQ: HRTX) through any online brokerage.
The latest price target for Heron Therapeutics (NASDAQ: HRTX) was reported by SVB Leerink on December 2, 2020. The analyst firm set a price target for 24.00 expecting HRTX to rise to within 12 months (a possible 46.16% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Heron Therapeutics (NASDAQ: HRTX) is $16.42 last updated Wed Jun 23 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Heron Therapeutics.
There is no upcoming split for Heron Therapeutics.
Heron Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.